FOI release

Freedom of Information responses from the MHRA - week commencing 5 April 2021

Medicines and Healthcare products Regulatory Agency (MHRA) responses to freedom of information (FOI) requests for week commencing 5 April 2021

• From: Medicines and Healthcare products Regulatory Agency
• Published: 28 May 2021

Documents

Freedom of Information request on use of live animals in independent batch testing of COVID-19 vaccines (FOI 21-218)

HTML

Freedom of Information request on the safety of COVID-19 vaccines (FOI 21-222)

HTML

Freedom of Information request on authorisation of COVID-19 vaccines (FOI 21-223)

HTML

Freedom of Information request on the Public Assessment Report for the Pfizer/BioNTech COVID-19 vaccine (FOI 21-224)

HTML

Freedom of Information request on the authorisation of the COVID-19 vaccines (FOI 21-225)

HTML

Freedom of Information request on adverse reactions to COVID-19 vaccines (FOI 21-229)

HTML

Freedom of Information request on adverse sexual dysfunction reactions to SSRI use (FOI 21-232)

HTML

Freedom of Information request on ICT department strategy and plans (FOI 21-234)

HTML

Freedom of Information request on adverse reactions to Priorix and the MMRVAXPRO vaccine (FOI 21-235)

HTML

Paper part 1 (FOI 21-235)

PDF, 52.7 KB, 31 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Paper part 2 (FOI 21-235)

PDF, 49.8 KB, 30 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Freedom of Information request on adverse reactions to influenza vaccines (FOI 21-242)

HTML

Paper part 1 (FOI-21-242)

PDF, 69.8 KB, 36 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Freedom of Information request on adverse reactions to COVID-19 Vaccine AstraZeneca (FOI 21-250)

HTML

Freedom of Information request on composition of Ibugel (FOI 21-256)

HTML

Freedom of Information request on reports of fatality after receiving the COVID-19 vaccine (FOI 21-262)

HTML

Freedom of Information request on the Risk Management Plan for Glycopyrronium Bromide 2mg Tablets (FOI 21-271)

HTML

Paper part 1 (FOI-21-271)

PDF, 1.9 MB, 74 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Freedom of Information request on LENTIS Hydrosmart foldable intraocular lenses (FOI 21-279)

HTML

Freedom of Information request on reports of fatalities after receiving a COVID-19 vaccine (FOI 21-284)

HTML

Details

See the MHRA FOI disclosure log.

See all FOI responses from the MHRA for 2021.

Published 28 May 2021